You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (4) |
Back to Search
PHARMACOGENETIC TESTING TO IDENTIFY PRESENCE OF THE HLA-B*57:01 BIOMARKER FOR ABACAVIR TREATMENT
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Poster
- Poster code: POS-TRI-002
- By: WIRTH, Francesca (UNIVERSITY OF MALTA, Pharmacy, Malta)
- Co-author(s): Leanne Camilleri: Department of Pharmacy, University of Malta, Msida, Malta
Francesca Wirth: Department of Pharmacy, University of Malta, Msida, Malta
Lilian M Azzopardi: Department of Pharmacy, University of Malta, Msida, Malta - Abstract:
Background
Testing for the HLA-B*57:01 pharmacogenetic (PGx) biomarker is clinically significant to predict risk of hypersensitivity reactions in patients to be treated with abacavir.
Methods
A literature search was performed to identify studies describing testing for HLA-B*57:01 with respect to therapy with abacavir. The studies were reviewed and
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026